Inhibrx Biosciences, Inc. (INBX)

79.00 +1.02 (+1.31%) USD  |  NASDAQ  |  Dec 31, 16:00
81.00 +2.00 (+2.53%) After-Hours: 20:00
More

Inhibrx Biosciences EV to CFO

EV to CFO Chart

View EV to CFO for INBX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Agenus, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Pelthos Therapeutics, Inc. Upgrade

EV to CFO Related Metrics

EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade